SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined…

Entrada Therapeutics, Inc. · CLUSTER filed Aug 31, 2026 at 18:26 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 31, 2026 at 18:26 ET

Two 10% owner entities (MPM BioVentures 2014 and 2018) sold a combined ~$1.44M of TRDA shares over five days, representing ~0.53% of market cap. The selling is part of a broader pattern of insider sales ($1.8M in prior 30 days), but the sellers are venture capital funds rather than C-suite executives, weakening the bearish signal per academic literature on insider sales.

  • MPM BioVentures 2014 and 2018 sold 8 blocks totaling ~$1.44M between Aug 26-31, 2026
  • Sales represent ~0.53% of TRDA's $273M market cap
  • Sellers are 10% owners (venture capital), not C-suite officers
  • Prior 30 days saw 10 insider sells totaling $1.8M, indicating a sustained distribution pattern

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access